维普中文期刊产品整合服务
63篇 您的检索式:作者名="Berry ML"
    题名 作者 年代 出处 被引量
1Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741/Caneer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oneol2003,21,8:1
2Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C97411Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
3Randomized trial of dose-dense versus conventionally scheduled and sequential versusconcurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:First report of Intergroup trial C9741/Cancer and Leukemia Group B trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
4Six weeks of balance training improves sensorimotor function in individuals with chronic ankle instability显示文摘Sefton JM Yarar C Hicks-Little CA Berry JW Cordova ML 0,,:1
5Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
6Fierce: a new mouse deletion of Nr2el ; violent behaviour and ocular abnormalities are background-dependent显示文摘Young KA Berry ML Mahaffey CL 2002Behav Brain Res2002,132,2:1
7Randomized trial of dose-dense versus Conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trail 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
8Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer; first report of intergroup trail C9741/Cancer and leukemia Group B trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Onco12003,21,8:1
9TGF-βsignalling-related markers in cancer patients with bone metastases显示文摘Baselga J Rothenberg ML Tabernero J Seoane J Daly T Cleverly A Berry B Rhoades SK Ray CA Fill J 0,,:1
10Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:First report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
11Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of In-tergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
12Nonuniform risk of bloodstream infection with increasing central venous catheter-days 显示文摘McLaws ML Berry G 2005Infect Control Hosp Epidemiol2005,26,8:1
13Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,:1
14Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
15Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer;first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
16Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node -positive primary breast cancer:first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
17Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,1,:1
18Randomized trial of dose-dense versus conventionally schedule and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer:first report of intergroup trial C9741/Cancer and leukemia group B trial 9741显示文摘Citro ML Berry DA Cirricione C 2003J Clin Oncol2003,27,7:1
19Diagnostic and prognostic significance of glomerular epithelial cell vacuolization and podocyte effacement in children with minimal lesion nephrotic syndrome and focal segmental glomerulosclerosis: an ultrastructural study显示文摘 Hawkins EP Berry PL 1988Clin Nephrol1988,30,:1
20Randomized trial of dosedense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741 显示文摘Citron ML Berry DA Cirrincione C 2003J Clin Oncol2003,21,8:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费